The study, published in Cancer Research, was co-led by Anil Korkut, Ph.D., associate professor of bioinformatics and computational biology.
“Our findings suggest that resistant cancer cells often adapt to find alternate pathways for survival,” Korkut said. “Current precision medicine approaches don’t account for these adaptive responses, which allow tumors to avoid being destroyed. Uncovering these backup routes can bring about more effective combination strategies to, ultimately, improve patient outcomes.”